Accelerated Stability Testing, And Why It Is An Estimate

The problem the method exists to solve is time. A question about how material behaves over two years cannot be answered in a month by waiting. It can be approached by running the same material harder and watching the degradation pathways appear faster, then working backwards through a rate model.

ICH Q1A(R2) sets out the conditions in a table, and they are worth quoting as numbers rather than as descriptions. For a solid held at controlled room temperature, long-term testing runs at 25 °C and 60% relative humidity for the full claimed period; accelerated testing runs at 40 °C and 75% relative humidity for 6 months, with measurements at 0, 3 and 6 months. An intermediate condition of 30 °C and 65% relative humidity exists for the case where the accelerated arm shows significant change.

Significant change is itself defined rather than judged: for a drug substance it includes failure to meet the specification for assay, degradation products, appearance or physical attributes. If the accelerated arm changes significantly, the projection from it is not used, and the intermediate condition becomes the basis instead.

The conditions, and what they are for

A detail that is frequently lost: for material in a semi-permeable or closed container, the chamber humidity is not the humidity the material experiences. A crimped glass vial with an intact elastomeric closure is a moisture barrier, so the 75% figure describes the stress on the container system rather than on the cake inside it. Studies on the substance itself, outside its final container, are a different experiment and answer a different question.

The rate model underneath it

The extrapolation is Arrhenius. Reaction rate constants rise exponentially with temperature according to an activation energy, so measuring the rate at two or more elevated temperatures allows the activation energy to be fitted and the rate at a lower temperature to be calculated. Activation energies for chemical degradation of peptides and proteins commonly fall in the region of 50 to 100 kJ per mole, determined by fitting rate constants across at least three temperatures.

The rule of thumb that circulates, that a 10 °C rise doubles the rate, corresponds to an activation energy near 53 kJ per mole at ordinary temperatures. It is a reasonable central figure and a poor assumption for any specific reaction. The table below shows how much the acceleration factor moves across the plausible range.

The consequence is that the same six-month accelerated run projects anywhere from roughly one year to over five years of equivalent time at 25 °C, depending entirely on a parameter that has to be measured for the specific degradation pathway. An accelerated result reported without the activation energy behind it is not a projection, it is an observation about six months at 40 °C.

The failure mode: a mechanism change above the glass transition

The Arrhenius assumption requires the same reaction to be rate-limiting at both temperatures. In an amorphous solid, which is what most lyophilized cakes are, that assumption breaks at the glass transition temperature of the dried material. Below it, molecular mobility in the matrix is so low that reaction rates are limited by the matrix rather than by chemistry. Above it, the solid becomes rubbery, mobility rises by orders of magnitude, and reactions that were effectively frozen out begin to run.

The glass transition temperature of a dried amorphous solid is not fixed: water is a plasticiser, and absorbed moisture lowers it steeply. A sucrose-containing cake with a glass transition temperature near 65 °C when dry can fall below 40 °C after taking up a few percent water by mass, measured by Karl Fischer titration. At that point the accelerated arm is no longer a faster version of the long-term arm. It is a different physical state with a different set of dominant reactions, and extrapolating from it overstates degradation, understates it, or simply predicts the wrong products.

• Deamidation of asparagine and glutamine and hydrolysis of the peptide bond are both strongly moisture-dependent, so their acceleration tracks matrix mobility rather than temperature alone.
• Oxidation depends on available oxygen and trace metal catalysts, which are not raised by heating the chamber, so an accelerated arm can systematically under-represent it.
• Physical changes, including crystallisation of an amorphous excipient, can occur at 40 °C and not at 25 °C, altering the matrix partway through the run.

What a stability study needs alongside it

A result is only interpretable if the analytical method can see degradation. A stability-indicating method is one demonstrated to resolve the parent peptide from its degradation products, which for reverse-phase HPLC is shown by forced-degradation studies: samples stressed by acid, base, oxidant, heat and light, each producing peaks the method separates from the main peak with adequate resolution. A method that co-elutes a degradant with the parent will report perfect stability for material that is changing.

Photostability is specified separately, in ICH Q1B, because light is not part of the thermal arms. The exposure is quantified: not less than 1.2 million lux hours of visible light and not less than 200 watt hours per square metre of near-ultraviolet energy.

Where we stand on this

Stability data are not among the specifications Aurum publishes. There is no accelerated arm, no long-term arm and no fitted activation energy in the published record for any material Aurum lists, and no shelf-life representation is made. What is published is a single time point: purity independently assayed by reverse-phase HPLC, and identity assayed by mass spectrometry. A purity figure from one point in time carries no information about the slope, and it is not presented as though it does. Published purity figures are HPLC purity and not net peptide content, which Aurum does not publish.